Clinical and Genomic Risk in Adjuvant Therapy for Breast Cancer. Reply

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	1290-1291
Number of pages	2
Journal	New England Journal of Medicine
Volume	381
Issue number	13
DOIs	https://doi.org/10.1056/NEJMc1909693
State	Published - 26 Sep 2019
Externally published	Yes

Access to Document

@article{ddddb5b587ce46c6b1d1b3990c0b50bb,

title = "Clinical and Genomic Risk in Adjuvant Therapy for Breast Cancer. Reply",

author = "Sparano, {Joseph A.}",

year = "2019",

month = sep,

day = "26",

doi = "10.1056/NEJMc1909693",

language = "English",

volume = "381",

pages = "1290--1291",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "13",

}

TY - JOUR

T1 - Clinical and Genomic Risk in Adjuvant Therapy for Breast Cancer. Reply

AU - Sparano, Joseph A.

PY - 2019/9/26

Y1 - 2019/9/26

UR - http://www.scopus.com/inward/record.url?scp=85072652589&partnerID=8YFLogxK

U2 - 10.1056/NEJMc1909693

DO - 10.1056/NEJMc1909693

M3 - Letter

C2 - 31553846

AN - SCOPUS:85072652589

SN - 0028-4793

VL - 381

SP - 1290

EP - 1291

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 13

ER -